For the year, Abbott forecast organic sales growth in the range of 6.5% to 7.5%, the midpoint of which missed Wall Street ...

ADJUSTED EARNINGS: Stripping out certain one-time items, earnings are forecast to come in at $1.50 a share. That compares with adjusted earnings of $1.34 a share a year earlier. REVENUE: Quarterly ...

CVS Health is slowly righting the ship after several challenging years. Abbott Laboratories' strong business should improve thanks to an acquisition. Both healthcare leaders have attractive long-term ...

On Friday, the three-judge appellate panel said only six Illinois families will continue with their infant-formula injury claims in the Cook County Circuit Court, while 23 other claims will have to ...

Records from December 9, 2025 indicate that Representative Richard Dean Dr McCormick of Georgia made a purchase of Abbott Laboratories (NYSE:ABT), valued between $26,026 and $390,000, with the ...

Abbott Laboratories is acquiring Exact Sciences, in a move that will help bolster its diagnostics business. Abbott should expand the reach of Exact Sciences' key products and fuel its innovative ...

Gift Article 10 Remaining As a subscriber, you have 10 articles to gift each month. Gifting allows recipients to access the article for free. Abbott Laboratories is moving to replace more than a ...

Exact agreed to be bought out by Abbott Labs for $105 per share. The buyout is at a hefty premium to the share price at the start of the week, but still well below Exact's 2021 highs. Shareholders ...

Forbes contributors publish independent expert analyses and insights. Bruce Japsen writes about healthcare business and policy. Abbott Laboratories $21 billion deal to acquire cancer test maker Exact ...

Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence. Subscribe to TipRanks' Smart Investor Picks and see our data in action through our ...